Share & more
Drug giant Bristol-Myers Squibb (BMS) on Friday marked the fifth anniversary of its AIDS initiative, "Secure the Future", with the launch of an HIV/AIDS centre in Lesotho.
The Senkatana Centre, one of five community-based HIV/AIDS treatment support programmes in southern Africa, is part of the ongoing US $100 million commitment announced by BMS in 1999.
BMS chairman Peter Dolan said in a statement: "Through 'Secure the Future', Bristol-Myers Squibb is helping to lead the global fight against the HIV/AIDS pandemic."
Dolan said the programme had pioneered the development of public-private partnerships that especially benefited women and children in one of the hardest-hit populations in the region.
This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions